How long can you live with conservative treatment of mid-to-late stage lung cancer

How long can you live with conservative treatment of mid-to-late stage lung cancer?

With the advent of targeted drugs, some patients with poor physical conditions have EGFR mutations detected through genetic testing. Oral Iressa treatment can extend their survival to 2-3 years, or even longer. When lung cancer develops to the middle and late stages, through genetic testing and oral Iressa treatment, the survival period can be extended to 2-3 years, or even longer.

How many times of chemotherapy is needed for small cell lung cancer?

Small cell lung cancer is a pathological type of lung cancer. It is highly malignant, develops and metastasizes rapidly, and is sensitive to chemotherapy drugs. Generally, chemotherapy is given in 4 to 6 courses, once a month. During chemotherapy, blood counts should be checked, nutritional support should be strengthened, immunity should be enhanced, and regular check-ups should be conducted to observe the effects of chemotherapy.

Most small cell lung cancers have no indication for surgical treatment. Comprehensive treatment with chemotherapy as the main treatment is conventionally 6 cycles of chemotherapy. Regular observation is the main treatment after chemotherapy. If the recurrence time is more than 6 months, the original chemotherapy can be continued. If the recurrence time is less than 3 months, the chemotherapy regimen should be changed. Lung cancer is divided into non-small cell lung cancer and small cell lung cancer according to pathological type. Small cell lung cancer is highly malignant. Although it is sensitive to radiotherapy, it progresses rapidly and is prone to recurrence.